00544nas a2200169   4500000000100000008004100001260002300042100001700065700001400082700001200096700001200108245012600120856008900246300000800335490000600343022002500349       2024                            d  bScientific Scholar1 aMuddebihal A1 aSardana K1 aKumar D1 aGupta S00aThe perils of prescribing second line anti-leprosy therapy for erythema nodosum leprosum ignoring resistance testing data  uhttps://ijdvl.com/view-pdf/?article=78a02ac2184c344148731af051d05de2V/jX6x7eB4xpYg==  a1-20 v0  a0973-3922, 0378-6323